Veregen® is an ointment used to treat external genital warts. In the USA and Canada, in 18 European countries (Germany, Austria, Switzerland, Spain, the Netherlands, Belgium, Norway, Denmark, Finnland, Sweden, the Czech Republic, Poland, Serbia, Hungary, Slovakia, Greece, Romania, Croatia) and Taiwan Veregen® is already marketed by our partners. Sales and marketing partnerships are also in place for this drug in a large number of other countries in Europe, Asia and America. An overview of our partners can be found here. The sales generated with Veregen® are continually rising and making a valuable contribution to financing the Company.
As an innovative drug, Veregen® is based on a defined extract from green tea leaves obtained in a highly complex and specifically developed process
Changes in a wart induced by Veregen®
Veregen® is an innovative drug formulation based on a defined extract from green tea leaves, which is obtained in a complex and specifically developed production process. In several clinical studies, Veregen® showed complete clearance of genital warts in more than 60% of the patients, and was very well tolerated. In its current treatment guidelines for sexually transmitted diseases, the US Center for Disease Control and Prevention recommends Sinecatechins 15% ointment (Veregen®) as a possible option for treating genital warts. In addition, Sinecatechins 10% and 15% ointment (Veregen®) were included in the current European guideline ("2012 European Guideline for the Management of Anogenital Warts”) as a recommended treatment option for genital warts.
Medigene has marketing agreements for Veregen® in place with numerous partners worldwide. Medigene receives one-time upfront payments, revenues from milestone payments and from the supply of the finished product, as well as royalties on the sales of Veregen® in these countries.
Medigene’s partners assume that the drug will be brought to market in other European states, including the UK and Ireland, in the coming months.
Veregen® is a trademark of Medigene AG.
Polyphenon E® is a trademark of Mitsui Norin Co., Ltd.